Stage IA NSCLC VATS Outcomes with Intrapleural Hemocoagulase

442 stage IA non-small cell lung cancer patients undergoing video-assisted thoracoscopic surgery were analyzed in a retrospective study. The data compares coagulation profiles and early recovery metrics between patients who received intrapleural Hemocoagulase Bothrops atrox (n=92) and those who did not (n=350). The dataset was authored by Yingding Ruan and last updated on 2026-04-10.

Use Cases

• Modeling the association between intrapleural HBA and postoperative coagulation parameters like prothrombin time and fibrinogen.
• Predicting postoperative complication risk based on treatment group and patient characteristics.
• Analyzing factors influencing length of hospital stay after VATS lung cancer surgery.

Strengths

• Dataset includes 442 patient records, providing a substantial cohort for analysis.
• Results report specific statistical measures (e.g., β coefficients, 95% CIs, p-values) for key outcomes.
• Analysis employed inverse probability of treatment weighting to balance baseline characteristics.

Limitations

• Row count for the underlying data table is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Data is contained in a 26.0 KB DOCX file, indicating a very limited scope likely focused on summary results.

Provenance

Source

figshare, authored by Yingding Ruan.

Collection Method

Retrospective analysis of patient records.

Time Range

null

Freshness

Last updated 2026-04-10 05:29:35; freshness should be verified.

Geography

null